Understanding Winstrol 50 Aaster Health and Sports Solutions
Winstrol 50mg from Aaster Health and Sports Solutions is a methylated dihydrotestosterone derivative extensively studied in androgenic research applications. This oral formulation contains stanozolol, a modified anabolic compound originally developed in the 1960s and subsequently investigated for its unique molecular properties. Researchers at Stroid UK Shop frequently examine this compound alongside other established references from our stanozolol tablets collection for comparative molecular studies.
Laboratory Applications
Stanozolol demonstrates distinctive binding characteristics at androgen receptors while exhibiting reduced 5α-reductase activity compared to testosterone in cellular models. Research protocols commonly investigate its methylated structure at the C17α position, which confers oral stability in digestive enzyme assays. Scientists studying anabolic pathways often compare stanozolol’s molecular behaviour with compounds available in our SARMs research section and peptides category to evaluate receptor selectivity patterns. The compound’s unique lack of aromatisation to estrogenic metabolites makes it valuable for studies requiring androgen receptor activation without concurrent estrogen pathway interference.
Product Specifications
| Parameter | Value |
|---|---|
| Active Compound | Stanozolol |
| Concentration | 50mg per tablet |
| Manufacturer | Aaster Health and Sports Solutions |
| Molecular Formula | C₂₁H₃₂N₂O |
| Molecular Weight | 328.49 g/mol |
| CAS Number | 10418-03-8 |
| Storage Requirements | Room temperature, dry environment |
Research Compliance
This stanozolol formulation is manufactured exclusively for in-vitro laboratory research and analytical testing purposes. Not intended for human consumption, therapeutic use, or any application outside controlled research environments. Researchers must maintain appropriate laboratory protocols and documentation when studying this compound.
